摘要
Objective To evaluate the long-term efficacy and safety of the implantable ventricular assist system EVAHEART I in clinical use.Methods Fifteen consecutive patients with end-stage heart failure who received left ventricular assist device therapy in Fuwai Hospital from January 2018 to December 2021 were enrolled in this study.
作者
陈海波
CHEN Haibo(Dept Cardiac Surg,Fuwai Hosp,CAMS&PUMC,Natl Cardiovas Dis Center,State Key Lab,Cardiovasc Dis,Beijing 100037)
